Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
Preferred features of oral treatments and predictors of non-adherence: two web-based choice experiments in multiple sclerosis patients.
Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis.
Something Old, New, Borrowed, Blue: Anthracenedione Agents for Treatment of Multiple Sclerosis.
Disease activity and disability evolution under glatiramer acetate: A clinical approach.
Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis.
The fatigue-motor performance paradox in multiple sclerosis.
Validity of the Dynamic Gait Index in People With Multiple Sclerosis.
Impact of simulated microgravity on oligodendrocyte development: implications for central nervous system repair.
Multiple sclerosis susceptibility alleles in African Americans.
Leber's optic neuropathy associated with disseminated white matter disease: a case report and review.
Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles.
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.
Using Twitter to investigate opinions about multiple sclerosis treatments: a descriptive, exploratory study.
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.
Neuroendocrine Responses to Transvascular Autonomic Modulation: A Modified Balloon Angioplasty in Multiple Sclerosis Patients.
Cell-Based Modulation of Autoimmune Responses in Multiple Sclerosis and Experimental Autoimmmune Encephalomyelitis: Therapeutic Implications.
Analysis of the direct injury effector of oligodendroglia cells or myelin sheath in an experimental allergic encephalomyelitis model induced by the MOG35-55 peptide.
[Ophthalmological Findings in Paediatric and Adolescent Multiple Sclerosis.]
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination.
Frequency of reported European ancestry among multiple sclerosis patients from four cities in the southern and southeastern regions of Brazil.
Neuromyelitis optica.
Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice.
A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
Is the IL-10 Promoter Polymorphism at Position -592 Associated with Immune System-Related Diseases?

Pages